EUVIMEDEUVIMED entdecken
Querschnittstudie

Potential Implications of Using Locally Validated Risk Factors for Drug-Resistant Pathogens in Patients With Community-Acquired Pneumonia in US Hospitals: A Cross-Sectional Study

Hamlet Gasoyan iD, Abhishek Deshpande, Peter B Imrey iD, Ning Guo, Benjamin G Mittman, Michael B Rothberg iD

Clinical Infectious Diseases · 2024

DOI: 10.1093/cid/ciae448 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift Clinical Infectious Diseases, 2024. Verfasst von Hamlet Gasoyan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Center for Value-Based Care Research, Department of Internal Medicine and Geriatrics, Primary Care Institute, Cleveland Clinic, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Community-Acquired Infections, Anti-Bacterial Agents, Methicillin-Resistant Staphylococcus aureus. Die Arbeit nennt 21 Literaturangaben. Gefördert von: AHRQ HHS, Agency for Healthcare Research and Quality.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The 2019 American Thoracic Society/Infectious Diseases Society of America (ATS/IDSA) community-acquired pneumonia (CAP) guidelines recommend that clinicians prescribe empiric antibiotics for methicillin-resistant Staphylococcus aureus or Pseudomonas aeruginosa only if locally validated risk factors (or 2 generic risk factors if local validation is not feasible) are present.

Methods

In this cross-sectional study that included adults hospitalized for CAP across 50 hospitals in the Premier Healthcare Database from 2010 to 2015, we sought to describe how the use of extended-spectrum antibiotics (ESAs) and the coverage for patients with CAP due to restraint organisms would change under the 2 approaches described in the 2019 ATS/IDSA guidelines. The proportion of ESA use in patients with CAP and the proportion of ESA coverage among patients with infections resistant to recommended CAP therapy were measured.

Results

In the 50 hospitals, 19%–75% of patients received ESAs, and 42%–100% of patients with resistant organisms received ESAs. The median number of risk factors identified per hospital was 9 (interquartile range, 6–12). Overall, treatment according to local risk factors reduced the number of patients receiving ESAs by 38.8 percentage points and by 47.5 percentage points when using generic risk factors. However, the effect varied by hospital. The use of generic risk factors always resulted in less ESA use and less coverage for resistant organisms. Using locally validated risk factors resulted in a similar outcome in all but 1 hospital.

Conclusions

Future guidelines should explicitly define the optimal trade-off between adequate coverage for resistant organisms and ESA use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Community-Acquired InfectionsAnti-Bacterial AgentsMethicillin-Resistant Staphylococcus aureusHumansCross-Sectional StudiesRisk FactorsMaleFemaleUnited StatesAgedMiddle AgedHospitalsPseudomonas aeruginosaPneumoniaAdultAged, 80 and overHospitalizationPneumonia, BacterialPractice Guidelines as Topic

Stichwörter der Autor:innen

Antimicrobial stewardshipCommunity-acquired pneumoniaExtended-spectrum antibiotics

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Center for Value-Based Care Research, Department of Internal Medicine and Geriatrics, Primary Care Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, Ohio, USA.
  • Department of Infectious Disease, Respiratory Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Quantitative Health Sciences, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio, USA.
  • Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.

ORCID-Profile: Hamlet Gasoyan, Peter B Imrey, Michael B Rothberg

Förderung

  • AHRQ HHS
  • Agency for Healthcare Research and Quality

Zitieren

APA

Gasoyan, H., Deshpande, A., Imrey, P. B., Guo, N., Mittman, B. G., & Rothberg, M. B. (2024). Potential Implications of Using Locally Validated Risk Factors for Drug-Resistant Pathogens in Patients With Community-Acquired Pneumonia in US Hospitals: A Cross-Sectional Study. Clinical Infectious Diseases. https://doi.org/10.1093/cid/ciae448

Vancouver

Gasoyan H, Deshpande A, Imrey PB, Guo N, Mittman BG, Rothberg MB. Potential Implications of Using Locally Validated Risk Factors for Drug-Resistant Pathogens in Patients With Community-Acquired Pneumonia in US Hospitals: A Cross-Sectional Study. Clinical Infectious Diseases. 2024. doi:10.1093/cid/ciae448

BibTeX
@article{Gasoyan2024,
  author = {Gasoyan, Hamlet and Deshpande, Abhishek and Imrey, Peter B and Guo, Ning and Mittman, Benjamin G and Rothberg, Michael B},
  title = {Potential Implications of Using Locally Validated Risk Factors for Drug-Resistant Pathogens in Patients With Community-Acquired Pneumonia in US Hospitals: A Cross-Sectional Study},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  doi = {10.1093/cid/ciae448}
}
Kostenlos starten →